NADPH oxidase 2 inhibitor GSK2795039 prevents doxorubicin-induced cardiac atrophy by attenuating cardiac sympathetic nerve terminal abnormalities and myocyte autophagy
Huiping Zhao, Yuan Ma, Xiaojuan Zhang, Hong-Xia Guo, Bin Yang, Rui‐Fang Chi, Nian-Ping Zhang, Jia‐Pu Wang, Bao Li, Fu‐Zhong Qin, Liguo Yang
Topics & Concepts
DoxorubicinInternal medicineMedicineEndocrinologyHeart failureNADPH oxidaseCardiotoxicityCardiomyopathyATG5MyocyteEjection fractionAutophagyChemistryApoptosisOxidative stressChemotherapyBiochemistryChemotherapy-induced cardiotoxicity and mitigationDiamond and Carbon-based Materials ResearchElectron Spin Resonance Studies